Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Ataxia and acute flaccid paralysis

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Rapid weakness or brainstem dysfunction

Ascending weakness, weak cough, bulbar symptoms, autonomic instability, altered consciousness, acute focal ataxia, severe headache or bladder and sensory-level change requires emergency neurological assessment.

Action: Use ABCDE, measure serial respiratory function, obtain ECG and blood-pressure monitoring, protect swallowing and arrange urgent brain or spinal imaging and paediatric neurology or intensive-care input according to localisation.

Synopsis

Localise acute gait and limb dysfunction, distinguish cerebellar disease from sensory or vestibular ataxia, detect Guillain-Barré respiratory failure and complete urgent UK public-health action for acute flaccid paralysis.

  • Ataxia is impaired coordination, not simply refusal to walk; observe truncal stability, gait base, eye movements, speech, finger-nose and heel-shin performance.
  • Separate cerebellar ataxia from sensory ataxia, vestibular imbalance and weakness by examining nystagmus, proprioception, Romberg, power and reflexes.
  • Acute ataxia in a child needs same-day assessment when sudden, persistent or accompanied by headache, vomiting, focal signs, reduced consciousness or toxin risk.
  • Guillain-Barré typically causes progressive symmetrical weakness with reduced or absent reflexes, often after infection; pain and autonomic symptoms are common in children.
  • Normal oxygen saturation and a normal early cerebrospinal fluid protein do not exclude evolving GBS; serial forced vital capacity, cough, bulbar function and autonomic observations are essential.
  • MRI brain is first-line for focal cerebellar or raised-pressure features; MRI spine is urgent for a sensory level, bladder dysfunction, back pain or upper motor-neurone signs.
  • Nerve-conduction studies support peripheral demyelination or axonal injury, while CSF classically shows raised protein with few cells after the first week.
  • IV immunoglobulin and plasma exchange are effective for non-ambulant or significantly progressive GBS; corticosteroids do not improve GBS recovery.
  • Any acute flaccid paralysis should prompt urgent UKHSA discussion and virological sampling, including two stool specimens 24–48 hours apart within 14 days of onset where the surveillance protocol advises.
  • Postinfectious acute cerebellar ataxia is a diagnosis of exclusion and should improve; deterioration or failure to recover triggers imaging and diagnostic review.

Key red flags

Rapidly ascending weakness, inability to walk, weak cough, drooling, nasal speech or orthopnoea suggests Guillain-Barré respiratory and bulbar progression.

Fluctuating tachycardia, bradycardia, hypertension or hypotension in acute flaccid weakness indicates dangerous autonomic involvement.

Acute ataxia with severe headache, vomiting, papilloedema, focal deficit or reduced consciousness requires urgent posterior fossa, stroke or raised-pressure imaging.

Back pain, a sensory level, brisk reflexes, sphincter dysfunction or asymmetric limb findings suggests spinal cord compression, myelitis or infarction.

Acute flaccid paralysis is a public-health syndrome: notify the appropriate UKHSA health protection team urgently and collect virology samples through the current polio-surveillance pathway.

Possible sedative, anticonvulsant, antihistamine, alcohol or recreational-drug access should trigger toxicology-focused assessment without premature functional diagnosis.

Investigation priorities

01
First-line glucose electrolytes and toxicology assessmentFirst stepFirst line

Identify reversible metabolic disturbance or ingestion in acute ataxia or weakness.

Management branches

TriageProtect breathing and localise

A child develops acute ataxia, inability to walk or flaccid weakness.

  1. Use ABCDE and assess cough, swallow, breathing pattern, vital capacity and autonomic observations.
  2. Map cerebellar, sensory, upper or lower motor-neurone features and examine bladder function.
  3. Admit rapidly progressive, bulbar, respiratory, focal or encephalopathic presentations urgently.

Key medicines

Intravenous immunoglobulinFor significantly progressive or non-ambulant paediatric Guillain-Barré syndrome, give a total 2 g/kg through the specialist protocol, usually 0.4 g/kg daily for 5 days or 1 g/kg daily for 2 days using the service's dosing weight.Screen for renal risk and thrombosis, monitor infusion reactions, haemolysis, aseptic meningitis and fluid load, and do not repeat automatically without neuromuscular specialist review.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG127 Neurological RecognitionUrgent referral for acute ataxia, weakness, swallowing and respiratory features.
  • NHS Guillain Barré SyndromeSymptoms, diagnosis, immunotherapy and recovery.
  • UKHSA Acute Flaccid Paralysis ReportingNotification and virological sampling for poliovirus surveillance.
  • UKHSA Polio National GuidelinesInvestigation, infection control and contact management for suspected polio.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom